AUG 04, 2020 8:04 AM PDT

Alzheimer's Blood Test Serves as a Crystal Ball

WRITTEN BY: Tara Fernandez

You can’t find your car keys, missed an important Zoom meeting, and draw a blank when it comes to planning what to cook for dinner. Just another weekday or red flags indicating the early signs of Alzheimer’s disease? According to a recent study, the answers could lie in a simple blood test.

Oskar Hansson, Professor of Clinical Memory Research at Lund University, Sweden led an international team of neuroscientists and neurologists who banded together as part of the BioFINDER study in search of improved early detection methods for Alzheimer's. 50 million people worldwide have Alzheimer’s or related dementia, but of these, experts suggest only 1-in-4 have been diagnosed. There is no accepted clinical procedure for diagnosing or predicting Alzheimer’s, with doctors typically getting confirmation only after a patient’s death. The presence of telltale amyloid plaques and tau tangles (clumps of misfolded proteins in the spaces between nerve cells) are pathologic markers confirming the devastating neurological condition.

The BioFINDER study identified a new biomarker circulating in the blood — phospho-tau217, or p-tau217 — which holds immense promise in predicting future onset, up to 20 years before cognitive symptoms begin.

"While more work is needed to optimize the assay and test it in other people before it becomes available in the clinic, the blood test might become especially useful to improve the recognition, diagnosis, and care of people in the primary care setting," said Hansson.

The researchers validated the p-tau217 blood test by recruiting over 1,400 participants from Arizona, Sweden, and Columbia who either showed signs of cognitive impairment or not. The assay demonstrated unprecedented accuracy and sensitivity: those with higher p-tau217 blood levels had a higher risk of developing Alzheimer’s. This correlated with clinical data with 98 percent accuracy.

According to Eric Reiman, MD, Executive Director of Banner Alzheimer's Institute in Phoenix and a senior author on the study, this new test has the potential to completely revolutionize the clinical approach to Alzheimer’s. "Blood tests like p-tau217 have the potential to revolutionize Alzheimer's research, treatment and prevention trials, and clinical care," said Reiman, adding, "While there's more work to do, I anticipate that their impact in both the research and clinical setting will become readily apparent within the next two years."

 

 

Sources: Science Daily, JAMA


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 20, 2021
Clinical & Molecular DX
Stressed Out Pregnant Mothers More Likely to Have Girls
APR 20, 2021
Stressed Out Pregnant Mothers More Likely to Have Girls
Scientists from the University of Granada used hair samples to monitor cortisol in a cohort of over 100 pregnant women a ...
JUN 07, 2021
Clinical & Molecular DX
COVID Test Results in a Second?
JUN 07, 2021
COVID Test Results in a Second?
Scientists have developed a handheld diagnostic device, capable of detecting the presence of the SARS-CoV-2’s spik ...
JUL 20, 2021
Clinical & Molecular DX
Wearable Health Monitors Powered by Sweaty Fingertips
JUL 20, 2021
Wearable Health Monitors Powered by Sweaty Fingertips
Fingertips have thousands of sweat-producing glands, churning out anywhere from 100 to 1,000 times more sweat than other ...
AUG 12, 2021
Clinical & Molecular DX
Computers Pick Up the 'Sound' of Thyroid Cancer
AUG 12, 2021
Computers Pick Up the 'Sound' of Thyroid Cancer
Researchers have developed a new technology for the non-invasive diagnosis of thyroid cancer that combines photoacoustic ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
SEP 08, 2021
Microbiology
Authorities Work to Contain Nipah Virus Outbreak in India
SEP 08, 2021
Authorities Work to Contain Nipah Virus Outbreak in India
Nipah virus is one of the world's deadliest viruses. It has caused several small outbreaks in Southeast Asia since it em ...
Loading Comments...